Mr Kasavilas said there were only a few companies in the world owning a legal source of cannabis, approved for scientific and medical research under international drug conventions.
‘There’s a bottleneck at the very top all around the world, where researchers are in need of a lawful source of cannabis to do any kind of research so they can do clinical trials.
Might be a clue in there for the MCL IPO?
Add to My Watchlist
What is My Watchlist?